Annual CFO
-$102.00 M
-$3.95 M-4.03%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual cash flow from operations is currently -$102.00 million, with the most recent change of -$3.95 million (-4.03%) on 31 December 2023. During the last 3 years, it has fallen by -$53.44 million (-110.03%). TNXP annual CFO is now -432116.10% below its all-time high of -$23.60 thousand, reached on 31 December 2008.TNXP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$18.80 M
-$8.88 M-89.55%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly cash flow from operations is currently -$18.80 million, with the most recent change of -$8.88 million (-89.55%) on 30 September 2024. Over the past year, it has increased by +$4.58 million (+19.60%). TNXP quarterly CFO is now -939950.00% below its all-time high of -$2000.00, reached on 30 June 2010.TNXP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$68.64 M
+$4.58 M+6.26%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding TTM cash flow from operations is currently -$68.64 million, with the most recent change of +$4.58 million (+6.26%) on 30 September 2024. Over the past year, it has increased by +$33.33 million (+32.69%). TNXP TTM CFO is now -762511.11% below its all-time high of -$9000.00, reached on 31 March 2008.TNXP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.0% | +19.6% | +32.7% |
| 3 y3 years | -110.0% | -45.2% | -2.4% |
| 5 y5 years | -325.5% | -182.9% | -155.9% |
TNXP Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -110.0% | at low | -89.5% | +42.9% | -2.4% | +32.8% |
| 5 y | 5 years | -325.5% | at low | -182.9% | +42.9% | -157.2% | +32.8% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +42.9% | <-9999.0% | +32.8% |
Tonix Pharmaceuticals Holding Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$18.80 M(+89.5%) | -$68.64 M(-6.3%) |
| June 2024 | - | -$9.92 M(-43.6%) | -$73.22 M(-15.5%) |
| Mar 2024 | - | -$17.57 M(-21.3%) | -$86.67 M(-15.0%) |
| Dec 2023 | -$102.00 M(+4.0%) | -$22.34 M(-4.5%) | -$102.00 M(+0.0%) |
| Sept 2023 | - | -$23.39 M(+0.1%) | -$101.96 M(-0.1%) |
| June 2023 | - | -$23.37 M(-29.0%) | -$102.11 M(+2.2%) |
| Mar 2023 | - | -$32.91 M(+47.6%) | -$99.92 M(+1.9%) |
| Dec 2022 | -$98.05 M(+29.8%) | -$22.30 M(-5.2%) | -$98.05 M(-0.1%) |
| Sept 2022 | - | -$23.54 M(+11.2%) | -$98.20 M(+12.1%) |
| June 2022 | - | -$21.17 M(-31.8%) | -$87.61 M(+2.4%) |
| Mar 2022 | - | -$31.05 M(+38.3%) | -$85.55 M(+13.2%) |
| Dec 2021 | -$75.56 M(+55.6%) | -$22.45 M(+73.4%) | -$75.56 M(+12.7%) |
| Sept 2021 | - | -$12.95 M(-32.2%) | -$67.03 M(-3.4%) |
| June 2021 | - | -$19.11 M(-9.3%) | -$69.36 M(+15.0%) |
| Mar 2021 | - | -$21.06 M(+51.3%) | -$60.30 M(+24.2%) |
| Dec 2020 | -$48.57 M(+82.0%) | -$13.91 M(-9.0%) | -$48.57 M(+17.5%) |
| Sept 2020 | - | -$15.29 M(+52.2%) | -$41.34 M(+26.4%) |
| June 2020 | - | -$10.04 M(+7.7%) | -$32.70 M(+19.5%) |
| Mar 2020 | - | -$9.33 M(+39.5%) | -$27.37 M(+2.6%) |
| Dec 2019 | -$26.68 M(+11.3%) | -$6.68 M(+0.6%) | -$26.68 M(-0.5%) |
| Sept 2019 | - | -$6.64 M(+41.0%) | -$26.82 M(+7.0%) |
| June 2019 | - | -$4.71 M(-45.5%) | -$25.07 M(-3.0%) |
| Mar 2019 | - | -$8.64 M(+26.6%) | -$25.84 M(+7.8%) |
| Dec 2018 | -$23.97 M(+25.3%) | -$6.82 M(+39.5%) | -$23.97 M(+8.6%) |
| Sept 2018 | - | -$4.89 M(-10.8%) | -$22.07 M(-0.7%) |
| June 2018 | - | -$5.49 M(-19.0%) | -$22.23 M(+5.3%) |
| Mar 2018 | - | -$6.77 M(+37.4%) | -$21.11 M(+10.3%) |
| Dec 2017 | -$19.13 M(-48.7%) | -$4.93 M(-2.4%) | -$19.13 M(-2.6%) |
| Sept 2017 | - | -$5.05 M(+15.8%) | -$19.64 M(-14.6%) |
| June 2017 | - | -$4.36 M(-9.1%) | -$22.99 M(-13.7%) |
| Mar 2017 | - | -$4.79 M(-11.9%) | -$26.62 M(-28.7%) |
| Dec 2016 | -$37.31 M | -$5.44 M(-35.2%) | -$37.31 M(-14.8%) |
| Sept 2016 | - | -$8.39 M(+5.0%) | -$43.78 M(-8.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | -$8.00 M(-48.4%) | -$47.72 M(-2.5%) |
| Mar 2016 | - | -$15.48 M(+30.0%) | -$48.96 M(+15.1%) |
| Dec 2015 | -$42.53 M(+86.2%) | -$11.91 M(-3.4%) | -$42.53 M(+9.5%) |
| Sept 2015 | - | -$12.32 M(+33.4%) | -$38.83 M(+23.8%) |
| June 2015 | - | -$9.24 M(+2.0%) | -$31.37 M(+12.7%) |
| Mar 2015 | - | -$9.05 M(+10.2%) | -$27.83 M(+21.8%) |
| Dec 2014 | -$22.84 M(+168.2%) | -$8.22 M(+69.1%) | -$22.84 M(+25.8%) |
| Sept 2014 | - | -$4.86 M(-14.7%) | -$18.15 M(+12.4%) |
| June 2014 | - | -$5.70 M(+40.2%) | -$16.16 M(+44.0%) |
| Mar 2014 | - | -$4.06 M(+15.1%) | -$11.22 M(+31.7%) |
| Dec 2013 | -$8.52 M(+49.1%) | -$3.53 M(+23.3%) | -$8.52 M(+31.2%) |
| Sept 2013 | - | -$2.86 M(+276.2%) | -$6.49 M(+31.7%) |
| June 2013 | - | -$761.00 K(-44.1%) | -$4.93 M(-7.0%) |
| Mar 2013 | - | -$1.36 M(-9.5%) | -$5.30 M(-7.3%) |
| Dec 2012 | -$5.71 M(+116.6%) | -$1.51 M(+15.8%) | -$5.71 M(+0.7%) |
| Sept 2012 | - | -$1.30 M(+15.1%) | -$5.67 M(+15.0%) |
| June 2012 | - | -$1.13 M(-36.4%) | -$4.93 M(+22.3%) |
| Mar 2012 | - | -$1.78 M(+21.2%) | -$4.03 M(+53.0%) |
| Dec 2011 | -$2.64 M(+113.9%) | -$1.47 M(+162.6%) | -$2.64 M(+10.2%) |
| Sept 2011 | - | -$558.50 K(+141.4%) | -$2.39 M(+30.3%) |
| June 2011 | - | -$231.40 K(-39.2%) | -$1.84 M(+14.3%) |
| Mar 2011 | - | -$380.90 K(-68.9%) | -$1.61 M(+30.4%) |
| Dec 2010 | -$1.23 M(+4320.4%) | -$1.22 M(>+9900.0%) | -$1.23 M(+9535.2%) |
| Sept 2010 | - | -$2000.00(0.0%) | -$12.80 K(-4.5%) |
| June 2010 | - | -$2000.00(-69.2%) | -$13.40 K(-47.0%) |
| Mar 2010 | - | -$6500.00(+182.6%) | -$25.30 K(-9.3%) |
| Dec 2009 | -$27.90 K(+18.2%) | -$2300.00(-11.5%) | -$27.90 K(-8.5%) |
| Sept 2009 | - | -$2600.00(-81.3%) | -$30.50 K(-6.7%) |
| June 2009 | - | -$13.90 K(+52.7%) | -$32.70 K(+39.1%) |
| Mar 2009 | - | -$9100.00(+85.7%) | -$23.50 K(+0.4%) |
| Dec 2008 | -$23.60 K | -$4900.00(+2.1%) | -$23.40 K(+26.5%) |
| Sept 2008 | - | -$4800.00(+2.1%) | -$18.50 K(+35.0%) |
| June 2008 | - | -$4700.00(-47.8%) | -$13.70 K(+52.2%) |
| Mar 2008 | - | -$9000.00 | -$9000.00 |
FAQ
- What is Tonix Pharmaceuticals Holding annual cash flow from operations?
- What is the all time high annual CFO for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual CFO year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly cash flow from operations?
- What is the all time high quarterly CFO for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly CFO year-on-year change?
- What is Tonix Pharmaceuticals Holding TTM cash flow from operations?
- What is the all time high TTM CFO for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding TTM CFO year-on-year change?
What is Tonix Pharmaceuticals Holding annual cash flow from operations?
The current annual CFO of TNXP is -$102.00 M
What is the all time high annual CFO for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual cash flow from operations is -$23.60 K
What is Tonix Pharmaceuticals Holding annual CFO year-on-year change?
Over the past year, TNXP annual cash flow from operations has changed by -$3.95 M (-4.03%)
What is Tonix Pharmaceuticals Holding quarterly cash flow from operations?
The current quarterly CFO of TNXP is -$18.80 M
What is the all time high quarterly CFO for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly cash flow from operations is -$2000.00
What is Tonix Pharmaceuticals Holding quarterly CFO year-on-year change?
Over the past year, TNXP quarterly cash flow from operations has changed by +$4.58 M (+19.60%)
What is Tonix Pharmaceuticals Holding TTM cash flow from operations?
The current TTM CFO of TNXP is -$68.64 M
What is the all time high TTM CFO for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high TTM cash flow from operations is -$9000.00
What is Tonix Pharmaceuticals Holding TTM CFO year-on-year change?
Over the past year, TNXP TTM cash flow from operations has changed by +$33.33 M (+32.69%)